NLRP3 and early-onset autosomal dominant Alzheimer disease: Indeed, increased NLRP3 activation is associated with several age-related pathological conditions, including Alzheimer’s disease, atherosclerosis and type-2 diabetes [91,92], whereas NLRP3 inhibition extends health-spans and diminishes age-dependent degenerative conditions [90].